Assessment of renal and cardiovascular risks in patients with type 2 diabetes when using non-steroidal mineralocorticoid receptor antagonists by V.М. Yerokhovych, Y.I. Komisarenko, O.V. Karpenko, V.I. Pankiv, N.M. Kobyliak, M.I. Bobryk, D.V. Kyriienko, K.S. Gurska, A.A. Kaplina, V.L. Vasiuk

Get full text